JAZZ
Jazz PublicCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
JAZZ vs peer average
50/100
JAZZ vs. peer average (C vs. C)
Grade spread
B 2 · C 5 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
EXEL is the first available peer comparator.
Exelixis is the cleanest operating comparator in the provided peer set for Jazz's commercial-oncology exposure: both are mid-cap biopharma companies with marketed cancer products and development-stage label or lifecycle work, though Jazz also has a large neuroscience franchise.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
JAZZ
Jazz Public
EXEL
Exelixis
Grade
C
C
Momentum
45
51
Value
63
65
Sentiment
36
33
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed
Grade position vs EXEL
JAZZ / EXEL
Grade Position
In line
JAZZ vs. peer average (C vs. C)
50/100
Momentum
45
EXELValue
63
EXELSentiment
36
JAZZRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs JAZZ
EXEL is the first peer returned for this comparison set.